JPS63218655A - Optical resolution of n-carbamoylmethionine - Google Patents
Optical resolution of n-carbamoylmethionineInfo
- Publication number
- JPS63218655A JPS63218655A JP5161387A JP5161387A JPS63218655A JP S63218655 A JPS63218655 A JP S63218655A JP 5161387 A JP5161387 A JP 5161387A JP 5161387 A JP5161387 A JP 5161387A JP S63218655 A JPS63218655 A JP S63218655A
- Authority
- JP
- Japan
- Prior art keywords
- ncm
- optically active
- eba
- carbamoylmethionine
- abbreviated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003287 optical effect Effects 0.000 title claims description 10
- DEWDMTSMCKXBNP-BYPYZUCNSA-N N-carbamoyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(N)=O DEWDMTSMCKXBNP-BYPYZUCNSA-N 0.000 title claims description 5
- 150000003839 salts Chemical class 0.000 claims abstract description 19
- 239000002904 solvent Substances 0.000 claims abstract description 7
- JCBPETKZIGVZRE-UHFFFAOYSA-N 2-aminobutan-1-ol Chemical compound CCC(N)CO JCBPETKZIGVZRE-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 12
- HVAAHUDGWQAAOJ-UHFFFAOYSA-N n-benzylethanamine Chemical compound CCNCC1=CC=CC=C1 HVAAHUDGWQAAOJ-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 12
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 5
- 238000009835 boiling Methods 0.000 abstract description 4
- 229930182817 methionine Natural products 0.000 abstract description 4
- AQFLVLHRZFLDDV-UHFFFAOYSA-N 1-phenylpropan-1-amine Chemical compound CCC(N)C1=CC=CC=C1 AQFLVLHRZFLDDV-UHFFFAOYSA-N 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 150000001298 alcohols Chemical class 0.000 abstract description 2
- 150000001413 amino acids Chemical class 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 239000003797 essential amino acid Substances 0.000 abstract description 2
- 235000020776 essential amino acid Nutrition 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 235000007983 food acid Nutrition 0.000 abstract 1
- 239000011369 resultant mixture Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000013078 crystal Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 238000001914 filtration Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- MEFKEPWMEQBLKI-AIRLBKTGSA-O S-adenosyl-L-methionine Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H]([NH3+])C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-O 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- -1 alkali metal salt Chemical class 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229940091173 hydantoin Drugs 0.000 description 2
- 229960002510 mandelic acid Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-M 5-oxo-L-prolinate Chemical compound [O-]C(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-M 0.000 description 1
- ULGJWNIHLSLQPZ-UHFFFAOYSA-N 7-[(6,8-dichloro-1,2,3,4-tetrahydroacridin-9-yl)amino]-n-[2-(1h-indol-3-yl)ethyl]heptanamide Chemical compound C1CCCC2=NC3=CC(Cl)=CC(Cl)=C3C(NCCCCCCC(=O)NCCC=3C4=CC=CC=C4NC=3)=C21 ULGJWNIHLSLQPZ-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- GSYTVXOARWSQSV-BYPYZUCNSA-N L-methioninamide Chemical compound CSCC[C@H](N)C(N)=O GSYTVXOARWSQSV-BYPYZUCNSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 108010003977 aminoacylase I Proteins 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 150000002741 methionine derivatives Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940071139 pyrrolidone carboxylate Drugs 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、式
%式%[00
で示される(±)−N−カルバモイルメチオニン(以下
(±)−NCMと略記する)の光学分割法に関するもの
である。Detailed Description of the Invention [Field of Industrial Application] The present invention relates to a method for optical resolution of (±)-N-carbamoylmethionine (hereinafter abbreviated as (±)-NCM) represented by the formula %[00]. It is related to.
メチオニンは必須アミノ酸の1つであり、家畜の配合飼
料、食品およびアミノ酸輸液などの医薬品等として需要
の多い化合物である。医薬品として用いる場合には光学
活性体が要求されることから、大量の光学活性メチオニ
ンを取得する方法が望まれている。Methionine is one of the essential amino acids, and is a compound in high demand as compound feed for livestock, foods, and pharmaceuticals such as amino acid infusions. Since an optically active form is required when used as a pharmaceutical, a method for obtaining a large amount of optically active methionine is desired.
光学活性メチオニンを光学分割により取得する方法とし
ては、種々の方法が提案されている。Various methods have been proposed for obtaining optically active methionine by optical resolution.
例えば、1)メチオニンをN−アセチル化し、その後ア
ンモニウム塩として優先晶析法により光学分割する方法
(特公昭39−24440号公報)、2)アシル化メチ
オニンをアミノアシラーゼを用いて酵素的に分割する方
法(薬誌、至、 113(1955))、3)メチオニ
ンアミドを酒石酸塩(薬誌、 73.357(1953
))やピロリドンカルボン酸塩(特公昭45−3225
0号公報)として分割する化学的方法、4)メチオニン
−マンデル酸複合体(特公昭58−1105号公報)と
して分割する方法等である。しかし、1)の方法は、−
回の生産量が極めて少なく、工業的には大規模な装置を
必要とし、設備に費用がかかるという欠点がある。また
2)の方法は、一度アシル化してアシル誘導体などとし
なければならず、また工業的には生物である酵素などを
使用するので不利である。3)の方法はメチオニンを誘
導体にしなければならないのが欠点である。4)の方法
は分割剤として用いるマンデル酸が回収しにくいという
欠点があり、未だ満足すべきものとは言い難い。For example, 1) methionine is N-acetylated and then optically resolved as an ammonium salt by preferential crystallization (Japanese Patent Publication No. 39-24440), 2) acylated methionine is enzymatically resolved using aminoacylase. Method (Yakushu, No. 113 (1955)), 3) Methionine amide is converted into tartrate (Yakushu, No. 73.357 (1953)
)) and pyrrolidone carboxylate (Special Publication No. 3225-1973)
4) A method of dividing as a methionine-mandelic acid complex (Japanese Patent Publication No. 58-1105). However, method 1) is -
The disadvantage is that the production volume per cycle is extremely small, and industrially, large-scale equipment is required and the equipment is expensive. In addition, method 2) requires acylation to produce an acyl derivative, and is disadvantageous from an industrial perspective because it uses biological enzymes. The disadvantage of method 3) is that methionine must be made into a derivative. Method 4) has the disadvantage that the mandelic acid used as the resolving agent is difficult to recover, and is still far from satisfactory.
現在、(±)−メチオニンは主にヒダントインを経由す
る合成法で工業的に製造されている。Currently, (±)-methionine is industrially produced mainly by a synthetic method via hydantoin.
このヒダントインを常圧下アルカリで加水分解すると容
易にN−カルバモイル体が得られ、このN−カルバモイ
ル体を加水分解すると容易に遊離α−アミノ酸となる。When this hydantoin is hydrolyzed with an alkali under normal pressure, an N-carbamoyl compound is easily obtained, and when this N-carbamoyl compound is hydrolyzed, it is easily converted into a free α-amino acid.
そこで本発明者らは、N−カルバモイルメチオニンが容
易に光学分割できれば、工業的に簡便かつ安価な光学活
性メチオニンの製造法となり得ると考え鋭意検討を重ね
た結果、光学活性なα−エチルベンジルアミン(以下E
BAと略記する)または2−アミノ−1−ブタノール(
以下2ABと略記する)を用いることにより、高光学純
度かつ高収率で(±) −NCMを光学分割できること
を見出し本発明を完成した。Therefore, the present inventors believed that if N-carbamoylmethionine could be easily optically resolved, it could be an industrially simple and inexpensive method for producing optically active methionine, and as a result of extensive investigation, they discovered that optically active α-ethylbenzylamine (hereinafter E
(abbreviated as BA) or 2-amino-1-butanol (abbreviated as BA) or 2-amino-1-butanol (abbreviated as BA) or 2-amino-1-butanol (
The present invention was completed by discovering that (±)-NCM can be optically resolved with high optical purity and high yield by using 2AB (hereinafter abbreviated as 2AB).
即ち、本発明は(±)−NCMに光学活性なEBAまた
は2ABを分割剤として作用させて、2種類のジアステ
レオマー塩を生成させて、光学分割する方法である。That is, the present invention is a method for optically resolving (±)-NCM by allowing optically active EBA or 2AB to act as a resolving agent to generate two types of diastereomer salts.
次に本発明の分割方法を具体的に述べる。まず、(±)
NCMに光学活性なEBAまたは2ABと溶媒を加
え、加熱溶解して過飽和となし、室温まで冷却した後、
必要とあれば難溶性の光学活性NCM−EBA塩または
NCM・2AB塩の種晶を少量接種して放置し、析出す
る同種の難溶性塩を分離する。Next, the dividing method of the present invention will be specifically described. First, (±)
Add optically active EBA or 2AB and a solvent to NCM, heat and dissolve to make supersaturated, cool to room temperature, and then
If necessary, a small amount of seed crystals of poorly soluble optically active NCM-EBA salt or NCM·2AB salt is inoculated and allowed to stand, and the precipitated same kind of sparingly soluble salt is separated.
使用する溶媒としては、水、アルコール類、ケトン類、
エステル類、またはこれらの混合物のような一般に光学
分割操作に使用される溶媒でよいが、水の場合はNCM
が水に難溶のため、NCMをアルカリ金属塩、アミン塩
、アンモニウム塩等にして水に溶解させ、同時にEBA
または2ABを塩酸塩として水に溶解し、これを加えて
反応させる。Solvents used include water, alcohols, ketones,
Solvents commonly used for optical resolution operations such as esters or mixtures thereof may be used, but in the case of water, NCM
Since it is poorly soluble in water, NCM is made into an alkali metal salt, amine salt, ammonium salt, etc. and dissolved in water, and at the same time, EBA
Alternatively, 2AB is dissolved in water as a hydrochloride, and this is added to react.
反応温度は反応溶媒の沸点以下で0℃以上であるが、好
ましくは50℃ないし沸点の範囲がよい。The reaction temperature is below the boiling point of the reaction solvent and above 0°C, preferably in the range from 50°C to the boiling point.
又、晶析温度は使用する溶媒の沸点以下であれば特に制
限はないが、0℃ないし50℃の範囲が好ましい。Further, the crystallization temperature is not particularly limited as long as it is below the boiling point of the solvent used, but it is preferably in the range of 0°C to 50°C.
ここで使用する光学活性EBAまたは2ABの量は、(
±) NCMに対して0.3〜1.5倍モル用いられ
るが、0.5〜1.2倍モル用いれば効率よく光学分割
されるので好ましい。The amount of optically active EBA or 2AB used here is (
±) 0.3 to 1.5 times the mole of NCM is used, but it is preferable to use 0.5 to 1.2 times the mole because efficient optical resolution can be achieved.
又ジアステレオマー塩の溶液をシリカゲルのクロマトグ
ラフィに付して分割してもよい。Alternatively, a solution of diastereomeric salts may be separated by chromatography on silica gel.
このようにして得られた光学活性NCM−EBA塩また
はNCM・2AB塩を、必要とあれば再結晶した後にア
ルカリを加えて塩を分解し、有機溶媒でEBAまたは2
ABを抽出除去し、塩酸、硫酸、硝酸等の鉱酸で中和す
ると、光学活性なNCMが析出する。これを濾取し、必
要とあればこれを再結晶することにより、純度の高いN
CMを得ることができる。The optically active NCM-EBA salt or NCM-2AB salt obtained in this way is recrystallized if necessary, then an alkali is added to decompose the salt, and EBA or 2AB salt is dissolved in an organic solvent.
When AB is extracted and removed and neutralized with a mineral acid such as hydrochloric acid, sulfuric acid, or nitric acid, optically active NCM is precipitated. By filtering this and recrystallizing it if necessary, highly pure N
You can get commercials.
また、有機溶媒により抽出した光学活性EBAまたは2
ABは、溶媒を減圧除去することにより容易に回収され
、再利用が可能である。In addition, optically active EBA or 2
AB can be easily recovered and reused by removing the solvent under reduced pressure.
次に実施例をあげて本発明をさらに詳細に説明する。 Next, the present invention will be explained in more detail with reference to Examples.
実施例1
(±) −N CM9.60 g (50mmol)に
、水酸化ナトリウム2.00g (50mmol)を水
25m1’に溶解した溶液を加え、撹拌しながら50℃
に加熱した。これに(+) −E B A4.05g(
30mmol )に1モル濃度塩酸30m1を加えた溶
液を加えた。さらに撹拌しながら70℃まで加熱して反
応を完結させた。これを冷却し、30℃で2時間放置し
、析出した結晶を濾別し、粗(+)−NCM・(+)
−EBA塩8.49g (26,Ommo 1 )を得
た。この塩を水30−で懸濁精製することにより、精(
+)−NCM・(+)−EBA塩5.85g(17,9
mmol)を得た。このものの物性は次の通りであった
。Example 1 A solution of 2.00 g (50 mmol) of sodium hydroxide dissolved in 25 ml of water was added to 9.60 g (50 mmol) of (±) -N CM, and the mixture was heated at 50°C with stirring.
heated to. To this (+) -E B A4.05g (
A solution of 30 mmol) and 30 ml of 1 molar hydrochloric acid was added. The reaction was completed by heating to 70° C. while stirring. This was cooled and left to stand at 30°C for 2 hours, and the precipitated crystals were filtered off to form crude (+)-NCM・(+).
-EBA salt 8.49 g (26, Ommo 1 ) was obtained. By suspending and purifying this salt in water, the purified (
+)-NCM・(+)-EBA salt 5.85g (17,9
mmol) was obtained. The physical properties of this product were as follows.
〔α)n” ; +3.3°(C1,メタノール)mp
; 179−184℃
用いたく±)−NCM中に含まれる(+)体に対する収
率; 71.6%
この塩に、水酸化ナトリウム0.82g (21,0m
mol)を水12m12に溶解した溶液を加え、遊離し
た(+)−EBAをベンゼンで抽出除去した。水層に濃
塩酸l、5rr+1を加え、析出した結晶を濾過後乾燥
して粗(+ ) −N CM2.43g(12,6mm
ol)を得た。[α)n”; +3.3° (C1, methanol) mp
; 179-184°C Yield based on the (+) form contained in ±)-NCM used; 71.6% To this salt, add 0.82 g of sodium hydroxide (21.0 m
A solution prepared by dissolving mol) in 12 ml of water was added, and the liberated (+)-EBA was extracted and removed with benzene. To the aqueous layer was added 1,5rr+1 of concentrated hydrochloric acid, and the precipitated crystals were filtered and dried to obtain 2.43g (12.6mm) of crude (+)-N CM.
ol) was obtained.
これを水20mj!で再結晶することにより精(+)−
N CMl、 99g(10,4mmol)を得た。こ
のものの物性は次の通りであった。This is 20mj of water! By recrystallizing with
99 g (10.4 mmol) of NCMl was obtained. The physical properties of this product were as follows.
〔α)n” ;+17.4°(C1,エタノール)mp
; 165−168℃
光学純度;100%
用いた(±)−NCM中に含まれる(+)体に対する収
率; 41.6%
尚、ベンゼン抽出の際のベンゼン層を1モル濃度塩酸2
5−で逆抽出することにより(+)−EBAの塩酸塩3
. Log(18,1mmol)を回収した。[α)n”; +17.4° (C1, ethanol) mp
; 165-168°C Optical purity: 100% Yield based on the (+) form contained in the (±)-NCM used; 41.6% The benzene layer during benzene extraction was diluted with 1 molar hydrochloric acid 2
Hydrochloride of (+)-EBA by back extraction with 5-
.. Log (18.1 mmol) was collected.
実施例2
(士ン −N CMl、92g(10mmol)と(+
) −E B A1、49g(llmmol)をメタノ
ール:水(6:1)混合溶媒14m!!に加熱溶解した
。室温に2時間放置して析出した結晶を濾別し、(+)
−NCM・(+)−EBA塩1.29g (3,9mm
ol)を得た。このもつの物性は次の通りであった。Example 2 (Shin-N CMl, 92 g (10 mmol) and (+
) -E B A1, 49g (llmmol) in methanol:water (6:1) mixed solvent 14ml! ! The mixture was heated and dissolved. The precipitated crystals were separated by filtration after being left at room temperature for 2 hours, and (+)
-NCM・(+)-EBA salt 1.29g (3.9mm
ol) was obtained. The physical properties of this motsu were as follows.
〔α)D” ; +t、 8°(C1,メタノール)m
p ; 191−195℃
用いた(±)−NCM中に含まれる(+)体に対する収
率; 78.0%
この塩に、水酸化ナトリウム0.24g (5,9mm
ol)を水2.5艷に溶かした溶液を加え、遊離した(
+)−EBAをエーテルで抽出除去し、水層に6規定塩
酸1rnI!を加え、析出した結晶を濾別後乾燥して(
+ ) −N CMo、 36g (1,9mmol)
を得た。このものの物性は次の通りであった。[α)D”; +t, 8° (C1, methanol) m
p; 191-195°C Yield based on the (+) form contained in the (±)-NCM used; 78.0% To this salt, 0.24 g of sodium hydroxide (5.9 mm
A solution of ol) dissolved in 2.5 liters of water was added to liberate (
+)-EBA was extracted and removed with ether, and 1rnI of 6N hydrochloric acid was added to the aqueous layer. was added, and the precipitated crystals were filtered and dried (
+ ) -N CMo, 36g (1.9mmol)
I got it. The physical properties of this product were as follows.
〔α〕。26; +16.2″’ (C1,エタノール
)mp ; 151−155℃
光学純度; 93.1%
用いた(±) −NCM中に含まれる(+)体に対する
収率; 3B、 0%
実施例3
(±) −N CMl、 92 g (10m+nol
)と(+)−2A 80.98g(llmmol)をメ
タノール:2−プロパツール(1: 1)混合溶媒10
mj!に加熱溶解した。[α]. 26; +16.2″' (C1, ethanol) mp; 151-155°C Optical purity; 93.1% Yield based on the (+) form contained in the (±)-NCM used; 3B, 0% Example 3 (±) -N CMl, 92 g (10m+nol
) and (+)-2A 80.98 g (llmmol) in methanol:2-propanol (1:1) mixed solvent 10
mj! The mixture was heated and dissolved.
室温に2時間放置して析出した結晶を濾過することによ
り粗(+)−NCM・ (+)−2AB塩1.54g
(5,5mmol)を得た。この塩を上記の混合溶媒5
.5rnlで再結晶し、精(+)−NCM−(+)−2
AB塩1. OOg (3,6mmo I)を得た。コ
ノモノノ物性は次の通りであった。By leaving it at room temperature for 2 hours and filtering the precipitated crystals, 1.54 g of crude (+)-NCM/(+)-2AB salt was obtained.
(5.5 mmol) was obtained. This salt is mixed with the above mixed solvent 5.
.. Recrystallize with 5 rnl to obtain pure (+)-NCM-(+)-2
AB salt 1. OOg (3,6 mmo I) was obtained. The physical properties were as follows.
〔α)、” ; −9,1°(C0,5,MeOH)f
U ; 111−118℃
用いた(土)−NCM中に含まれる(+)体に対する収
率;72%
この塩に6M塩酸0.6−を加え、析出した結晶を濾過
することにより(+) −N CMo、 56g (2
,9mmol)を得た。このものの物性は次の通りであ
った。[α),”; −9,1°(C0,5,MeOH)f
U; 111-118°C Yield based on the (+) body contained in the (Sat)-NCM used; 72% By adding 6M hydrochloric acid 0.6- to this salt and filtering the precipitated crystals, the (+) -N CMo, 56g (2
, 9 mmol) was obtained. The physical properties of this product were as follows.
〔α)、” ; −13,8°(C1,エタノール)m
p; 145−152 ℃
光学純度;79%
用いた(±)−NCM中に含まれる(+)体に対する収
率;58%[α),”; −13,8° (C1, ethanol) m
p: 145-152°C Optical purity: 79% Yield based on the (+) form contained in the (±)-NCM used: 58%
Claims (1)
エチルベンジルアミンまたは2−アミノ−1−ブタノー
ルを溶媒中で反応させ、生成するジアステレオマー塩を
分割することを特徴とする(±)−N−カルバモイルメ
チオニンの光学分割法。(±)-N-Carbamoylmethionine optically active α-
An optical resolution method for (±)-N-carbamoylmethionine, which comprises reacting ethylbenzylamine or 2-amino-1-butanol in a solvent and separating the diastereomeric salts produced.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5161387A JPH0784433B2 (en) | 1987-03-06 | 1987-03-06 | Optical resolution of N-carbamoylmethionine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5161387A JPH0784433B2 (en) | 1987-03-06 | 1987-03-06 | Optical resolution of N-carbamoylmethionine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63218655A true JPS63218655A (en) | 1988-09-12 |
| JPH0784433B2 JPH0784433B2 (en) | 1995-09-13 |
Family
ID=12891747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5161387A Expired - Lifetime JPH0784433B2 (en) | 1987-03-06 | 1987-03-06 | Optical resolution of N-carbamoylmethionine |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0784433B2 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008297281A (en) * | 2007-06-01 | 2008-12-11 | Daito Kagaku Kk | Process for producing optically active N-benzyloxycarbonylamino acid and diastereomeric salt |
| WO2013011999A1 (en) * | 2011-07-20 | 2013-01-24 | 株式会社カネカ | Method for producing optically active 2-methylproline derivative |
| CN103288699A (en) * | 2012-02-24 | 2013-09-11 | 中国药科大学 | Preparation method of proline analogue |
-
1987
- 1987-03-06 JP JP5161387A patent/JPH0784433B2/en not_active Expired - Lifetime
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008297281A (en) * | 2007-06-01 | 2008-12-11 | Daito Kagaku Kk | Process for producing optically active N-benzyloxycarbonylamino acid and diastereomeric salt |
| WO2013011999A1 (en) * | 2011-07-20 | 2013-01-24 | 株式会社カネカ | Method for producing optically active 2-methylproline derivative |
| CN103702981A (en) * | 2011-07-20 | 2014-04-02 | 株式会社钟化 | Method for producing optically active 2-methylproline derivative |
| JPWO2013011999A1 (en) * | 2011-07-20 | 2015-02-23 | 株式会社カネカ | Process for producing optically active 2-methylproline derivative |
| CN103288699A (en) * | 2012-02-24 | 2013-09-11 | 中国药科大学 | Preparation method of proline analogue |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0784433B2 (en) | 1995-09-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4298212B2 (en) | Method for producing high melting point type epinastine hydrochloride | |
| US4224239A (en) | Process for preparing optically active amino acid or mandelic acid | |
| FI101534B (en) | New method for synthesizing levodopa | |
| US4319040A (en) | Process for the production of optically active threo-3-(3,4-dihydroxyphenyl)serine | |
| USRE29588E (en) | Preparation of d-2-amino-1-butanol salts | |
| JPH0813801B2 (en) | Method for purifying tryptophan | |
| JP3273578B2 (en) | Method for producing salt of ornithine with acidic amino acids or keto acids | |
| US4005088A (en) | Process for the chemical separation of racemic modifications of α-aminocarboxylic acid derivatives, and cinchonidine salt intermediates | |
| JPS63218655A (en) | Optical resolution of n-carbamoylmethionine | |
| EP0611369B1 (en) | Process for preparing (s) (+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) | |
| JP3716376B2 (en) | Optical resolving agent and method for producing optically active 3-aminopyrrolidine derivative using the same | |
| JPS61500615A (en) | chemical synthesis | |
| US3939172A (en) | 4-Aminothiazole | |
| WO1985003932A1 (en) | Novel diastereomer salts of phenylalanine and n-acyl derivatives thereof and process for the separation of optically active phenylalanine and n-acyl derivatives thereof | |
| JPH0131517B2 (en) | ||
| JPS6360955A (en) | Manufacture of l-dopa | |
| EP0320898A2 (en) | Processes and compounds useful for resolving 1-methyl-3-phenylpropylamine | |
| US6008403A (en) | Method for producing optically active amino acid of derivative thereof having high optical purity | |
| JPS6139299B2 (en) | ||
| JPS6259274A (en) | Method for producing optically active phenylserine derivatives | |
| JP2823679B2 (en) | Method for producing optically active 2-methylpiperazine | |
| US4011210A (en) | 4-sulfanilamidothiazole | |
| JPS58188862A (en) | Preparation of n-acylcarnosine | |
| JPS61172846A (en) | Method of optical resolution of (+-)-2-chloroprorionic acid | |
| Zhang et al. | A highly efficient preparation of NG-methyl-L-arginine and NG-methyl-D-arginine |